Arsenal’s Value Demonstration Acquires Guidemark Health Following Recent BresMed Health Solutions and Cello Health Acquisitions

Arsenal Capital Partners has acquired Guidemark Health, following its acquisitions of Cello Health and BresMed Health Solutions last year. Arsenal’s Value Demonstration will advance advance R&D in a variety of therapeutic areas including oncology and rare diseases. The organization will also improve patient access to novel therapies.

Guidemark CEO Michael Parisi remarks, “We are thrilled to join a rapidly growing organization with a complementary mission and vision to our own. Together, we will provide a leading strategic and full service communication offering for healthcare clients with the highest quality insights, evidence, advice, and support needed to realize their ambitions and maximize the value of their products,” adding, “This is an important step for everyone at Guidemark, and we couldn’t be more excited to be a part of this world-class organization.” Read more here.

(Source: Cision PR Newswire, 11/2/21)